BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT06111326 · UNKNOWN
Trial details
- NCT number
- NCT06111326
- Sponsor
- Biocity Biopharmaceutics Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2024-08-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.